Physician profile
Jay Kim
NPI 1821077553
$3,303.32
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,177 · 2020: $447 · 2021: $421 · 2022: $1,229 · 2023: $30.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,271.55 | 2021-2023 | Endurant Iis |
| Endologix LLC | $1,220.29 | 2019-2021 | |
| Clearflow INC. | $223.41 | 2019 | |
| Abbvie INC. | $125.00 | 2021 | |
| Ethicon INC. | $106.26 | 2021 | |
| Cook Medical LLC | $60.66 | 2019-2020 | |
| Abbott Laboratories | $59.82 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.13 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $26.44 | 2021 | |
| Lemaitre Vascular, INC. | $22.25 | 2020 | |
| Amarin Pharma, INC. | $22.03 | 2021 | |
| Boston Scientific Corporation | $20.59 | 2019 | |
| Bard Access Systems, INC. | $20.18 | 2019 | |
| Kci USA, INC. | $19.54 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $16.64 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.31 | 2021 | |
| Merck Sharp & Dohme LLC | $15.14 | 2022 | |
| Lsi Solutions INC | $12.20 | 2020 | |
| Kls-Martin L.P. | $11.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.